Literature DB >> 9034980

HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases.

D Ou1, L A Mitchell, A J Tingle.   

Abstract

The association of individual autoimmune diseases with multiple HLA molecules has remained an enigma. That T cells can recognize the same peptide presented by several different HLA-DR alleles (i.e., promiscuous recognition) has been well documented. To explain this, we propose the "DR restrictive supertype pattern (DR RSP)" hypothesis. We focus on the known amino acid polymorphisms at positions beta 70, beta 71, and beta 74 located within pocket 4 of the DR molecule and their potential influence on promiscuous T cell recognition. We have shown that HLA-DR alleles may be grouped, on the basis of their polymorphisms at these positions, into at least 6 sets of DR alleles, 4 of which share, respectively, one of the RSP: A (Q/RR/KA), D (DE/R[K]A/L), E (Q/RRE), or R (QKR/Q) and 2 of which share the restrictive patterns Q (DRQ) or a (QAA). Most of the RSP have been shown to be associated with promiscuous T cell recognition of antigenic peptides. We also provide a rationale on how different DR alleles, exhibiting a particular RSP, might be capable of binding an antigenic peptide and presenting it, in a promiscuous fashion, to peptide-specific T cells. By identifying these RSP represented by DR alleles that have been clinically associated with certain autoimmune disease, we also extend the DR RSP hypothesis to account for the association of certain autoimmune diseases with multiple HLA-DR alleles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034980

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis.

Authors:  E G de la Concha; M Fernandez-Arquero; A Martinez; P Vigil; F Vidal; G Lopez-Nava; M Diaz-Rubio; J Garcia-Paredes
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

3.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

4.  Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.

Authors:  Marco Galluzzo; Simone D'Adamio; Elena Campione; Luca Bianchi; Marina Talamonti
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

5.  Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information.

Authors:  Marina Talamonti; Marco Galluzzo
Journal:  Ann Transl Med       Date:  2020-08

6.  Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.

Authors:  Bernhard Knapp; Gottfried Fischer; Dries Van Hemelen; Ingrid Fae; Bernard Maillere; Christof Ebner; Wolfgang Schreiner; Barbara Bohle; Beatrice Jahn-Schmid
Journal:  BMC Immunol       Date:  2012-08-08       Impact factor: 3.615

7.  Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centre.

Authors:  M Guarene; C Capittini; A De Silvestri; A Pasi; C Badulli; I Sbarsi; A L Cremaschi; F Garlaschelli; C Pizzochero; M C Monti; C Montecucco; G R Corazza; D Larizza; P E Bianchi; L Salvaneschi; M Martinetti
Journal:  Biomed Res Int       Date:  2013-01-21       Impact factor: 3.411

Review 8.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.

Authors:  Jörg Christoph Prinz
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

9.  Development of a novel clustering tool for linear peptide sequences.

Authors:  Sandeep K Dhanda; Kerrie Vaughan; Veronique Schulten; Alba Grifoni; Daniela Weiskopf; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Immunology       Date:  2018-08-06       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.